BIOSCIENCE HEALTH INNOVATIONS INC. (BHIC)

4.55 -8.63% (-0.43)

Over 6M: +13.7%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

2 4 6
Mar Apr May Jun Jul Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q2 '22 — Net Income: -1.9K Q3 '22 — Net Income: -3.7K Q3 '22 — Net Income: -84.7K Q4 '22 — Net Income: -28.9K Q4 '22 — Net Income: -79.7K Q1 '23 — Net Income: -20K Q1 '23 — Net Income: -70.7K Q2 '23 — Net Income: -85.3K Q3 '23 — Net Income: -57.1K Q4 '23 — Net Income: -38.4K Q1 '24 — Net Income: -53.4K Q2 '24 — Net Income: 74.2K Q3 '24 — Net Income: 56.2K Q4 '24 — Net Income: 10K Q1 '25 — Net Income: 426.8K Q2 '25 — Net Income: 457.7K Q3 '25 — Net Income: -8.8K Q4 '25 — Net Income: -233.6K Q1 '26 — Net Income: -229.9K Q2 '26 — Net Income: -185.8K -150K 0 150K 300K 450K 600K
Q3 '22 Q4 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.4
OE margin -34.2%
Oper. margin -13.7%
ROIC -35.0%
Gross margin 53.8%
Accruals 41.1%
FCF margin -34.2%
OCF margin -34.2%
Profit margin -14.7%
ROA -30.8%
ROE -35.9%
Capex / sales —
EBITDA margin —
OCF / EBIT —
ROCE —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

3.2
RPO / sales 0.00057×
RPO growth —
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

5.0
ND/EBITDA —
Cash runway 0.29 yr
Cash / Debt 2.7×
Debt / Eq 0.14×
Debt payback 0.0 yr
F-score 5.1 pts
Current ratio —
Interest cover —
Payout —
Quick ratio —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.2
Sales/sh Y/Y +3.1%
EPS Y/Y -166.2%
Sales Q/Q -41.0%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS next Y —
Sales CAGR 4Y —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.